Page 4 - Qiagen Putin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Qiagen putin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Qiagen Putin Today - Breaking & Trending Today

Qiagen (NYSE:QGEN) Rating Increased to Buy at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of Qiagen (NYSE:QGEN – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Thursday morning, Marketbeat.com reports. The firm currently has $50.00 price target on the stock. Several other analysts have also recently weighed in on QGEN. JPMorgan Chase & […] ....

Robertw Baird , Goldman Sachs Group , Raymond James Associates , Jpmorgan Chase Co , Sei Investments Co , Dimensional Fund Advisors , Vanguard Group Inc , Free Report , Moderate Buy , Trading Down , Get Free Report , Fund Advisors , Vanguard Group , Qiagen Daily , Nyse Qgen , The Goldman Sachs Group Inc ,

Financial Analysis: Taysha Gene Therapies (NASDAQ:TSHA) & Qiagen (NYSE:QGEN)

Qiagen (NYSE:QGEN – Get Free Report) and Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 58.0% of Qiagen shares […] ....

United States , University Of Texas Southwestern Medical Center , Taysha Gene Therapies Inc , Get Free Report , Taysha Gene Therapies , Taysha Gene Therapie , Taysha Gene , Given Taysha Gene Therapie , Gene Therapies , Texas Southwestern Medical Center , Qiagen Daily , Nyse Qgen , Stock Comparison , Stock Analysis ,

Panagora Asset Management Inc. Sells 79,971 Shares of Qiagen (NYSE:QGEN)

Panagora Asset Management Inc. lessened its position in Qiagen (NYSE:QGEN – Free Report) by 68.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 36,504 shares of the company’s stock after selling 79,971 shares during the quarter. Panagora Asset Management […] ....

Robertw Baird , Dekabank Deutsche Girozentrale , Arrowstreet Capital Limited Partnership , Securities Exchange Commission , Norges Bank , Panagora Asset Management Inc , Vanguard Group Inc , Jpmorgan Chase Co , Panagora Asset Management , Free Report , Asset Management , Capital Limited Partnership , Bank Deutsche Girozentrale , Get Free Report , Qiagen Daily , Nyse Qgen , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

QIAGEN launches complete Sample to Insight workflow for microbiome research

Simplified and accelerated research workflow including high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis // Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias // Expanding growing portfolio of QIAGEN microbiome solutions, covering every aspect of the scientific workflowVenlo, the Netherlands, Nov. 06, ....

Daniela Berheide , Phoebe Loh , John Gilardi , Thomas Theuringer , Dieterm Tourlousse , Life Sciences , Exchange Commission , Us Securities Exchange , Library Kit , Head Of The Life Sciences Business Area , National Institute Of Advanced Industrial Science , Frankfurt Prime Standard , Nitin Sood , Senior Vice President , Life Sciences Business Area , Powerfecal Pro , Powersoil Pro , Normalizer Kit , Senior Scientist , National Institute , Advanced Industrial Science , Microbial Analysis Portal , Molecular Diagnostics , Exchange Act , Annual Report , Rna Extraction ,

Qiagen (NYSE:QGEN) PT Lowered to $42.00

Qiagen (NYSE:QGEN – Get Free Report) had its price target dropped by equities researchers at UBS Group from $48.00 to $42.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the stock. UBS Group’s price target points to a potential upside of 9.92% from the stock’s previous […] ....

Robertw Baird , Riverview Trust Co , Altshuler Shaham Ltd , Park Place Capital Corp , Wealthplan Partners , Assetmark Inc , Get Free Report , Place Capital Corp , Shaham Ltd , Qiagen Daily , Nyse Qgen , Lower Price Target , Ubs Group Ag ,